Contrast-enhanced breath-hold three-dimensional magnetic resonance angiography in the evaluation of renal arteries: optimization of technique and pitfalls.
The authors describe the optimization of a contrast-enhanced, breath-held, three-dimensional magnetic resonance angiography (CE-BH-3DMRA) technique in the assessment of the renal arteries and compare its utility with conventional x-ray angiography (XRA). Signal optimization using specific pulse sequence parameters was based on the patient's circulatory conditions, injection rate, and pulse sequence timing. Fifty-one patients (27 M, 24 F; mean age 69.7 years) were evaluated with CE-BH-3DMRA and XRA. All patients had an MR angiogram 3 months either before or after XRA. A test bolus study was performed for accurate assessment of transit time in each patient. A total of 51 patients (115 vessels) were studied in which the sensitivity and specificity for all renal artery stenoses including the proximal and mid-renal arterial segments were 96% and 92%, respectively. In-stent stenosis could only be diagnosed by quantifying flow beyond the stent using an additional triggered phase contrast cine pulse sequence. A total of 11 accessory renal arteries were correctly identified. In addition, fibromuscular dysplasia in two patients and stents in three patients were correctly identified on MRA. J. Magn. Reson. Imaging 2000;12:912-923.
Shetty
A N
AN
Department of Diagnostic Radiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA. ashetty@beaumont.edu
Bis
K G
KG
Kirsch
M
M
Weintraub
J
J
Laub
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001783:Blood Flow Velocity / Q000502:physiology; D005260:Female; D005352:Fibromuscular Dysplasia / Q000175:diagnosis / Q000628:therapy; D006083:Graft Occlusion, Vascular / Q000175:diagnosis; D006801:Humans; D021621:Imaging, Three-Dimensional; D018810:Magnetic Resonance Angiography / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012077:Renal Artery / Q000473:pathology; D012078:Renal Artery Obstruction / Q000175:diagnosis* / Q000628:therapy; D012680:Sensitivity and Specificity; D015607:Stents